CT FOR DRUG RES AND DEV has a total of 12 patent applications. Its first patent ever was published in 2014. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are BFB ET RECH EX, EMCURE PHARMACEUTICALS LTD and KLUGER RONALD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Canada | 2 | |
#3 | China | 2 | |
#4 | Republic of Korea | 1 | |
#5 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Hedberg Bradley John | 8 |
#2 | Rich James R | 8 |
#3 | Winters Geoffrey C | 7 |
#4 | Babcook John | 6 |
#5 | Hsieh Tom Han Hsiao | 5 |
#6 | Bourque Elyse Marie Josee | 5 |
#7 | Mandel Alexander Laurence | 5 |
#8 | Bourque Elyse Marie Josée | 3 |
#9 | Hughes Michael R | 2 |
#10 | Mcnagny Kelly Marshall | 2 |
Publication | Filing date | Title |
---|---|---|
CA2928043A1 | Anti-podocalyxin antibodies and methods of using the same | |
WO2014183221A1 | Resveratrol analogs and therapeutic uses thereof |